Adverse events of epidiolex: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
On June 25, 2018, the FDA granted approval to Epidiolex oral solution, marking it as the first cannabis-derived medication with a highly...
![Neurological Aliance Logo Picture1[24167].png](https://static.wixstatic.com/media/a3e381_7644263bc506403d8f8ee4cb959acb66~mv2.png/v1/fill/w_246,h_75,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Neurological%20Aliance%20Logo%20Picture1%5B24167%5D.png)